Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Reprod Toxicol ; 117: 108356, 2023 04.
Article in English | MEDLINE | ID: mdl-36828160

ABSTRACT

Although sertraline is considered one of the safest antidepressants in the lactation period, there are still few studies that assess its impact on child development. Therefore, this experimental study aimed to clarify the effect of sertraline on the neurobehavioral and reproductive development of male rats. Thus, 30 lactating rats were divided into 3 experimental groups (n = 10/group): CO- received filtered water, S10 and S20 groups that received, respectively, 10 and 20 mg/kg/day of sertraline. Treatment was performed by gavage, from postnatal days (PND) 1-20. During this period, the reflex and somatic development of rats were observed, as well as maternal behavior. On PND 21, mothers were euthanized and the organs were weighed. On PND 21, 45, and 100, one male from each litter was euthanized for histological and immunohistochemical (PCNA and WT1) analysis of the reproductive organs. The growth of body weight, the anogenital distance (AGD), the time to puberty, sperm quality, sexual behavior, neurobehavior, and natural fertility were also verified. Statistical analysis: One-way ANOVA or Kruskal-Wallis test (p ≤ 0.05). The results showed that mothers in the S20 group had an increase in thyroid weight. The male offspring exposed to sertraline had lower body weight (PND 7), lower AGD (PND 7 and 14), and delay in reflex development, in addition to histological alterations in the testis (PND 21). In adulthood, sperm quality was altered, without compromising natural fertility. Therefore, the present study found important alterations in the reflex and reproductive development of male rats exposed to sertraline during lactation.


Subject(s)
Lactation , Prenatal Exposure Delayed Effects , Female , Humans , Rats , Animals , Male , Sertraline/toxicity , Maternal Health , Maternal Exposure/adverse effects , Sexual Maturation , Semen , Body Weight , Prenatal Exposure Delayed Effects/chemically induced
2.
Reprod Toxicol ; 116: 108336, 2023 03.
Article in English | MEDLINE | ID: mdl-36669626

ABSTRACT

Selective serotonin reuptake inhibitors (SSRIs) are prescribed to pregnant women for treating mental illnesses. Among the drugs of this class, sertraline (ST) is the antidepressant therapy recommended most frequently. Therefore, this study aimed to evaluate the impact of gestational ST treatment on reproductive parameters and toxicological target organs of rat female offspring, as well as on somatic, reflex and neurobehavioral development, in a model of maternal adversity. Pregnant Wistar rats received vehicle (filtered water) or ST hydrochloride (20 mg/Kg/day diluted in vehicle) by oral gavage, associated or not with restraint stress for 1 h/day from gestational days 13-20. F1 female offspring was evaluated on reproductive parameters, body weight and somatic and reflex milestones from postnatal day (PND) 1. On PNDs 25 and 72, the elevated-plus-maze test was performed, while toxicological target organs were evaluated on PNDs 42 and 80. In utero exposure to ST, regardless of exposure to stress, reduced body weight at birth and affected the somatic development and estrous cycle. The absolute and relative thyroid weights were increased in Stress/ST group during puberty and adulthood, while the percentage of ovarian structures and the absolute uterine weight were altered in this group on PND 80. Prenatal exposure only to ST reduced initial body weight gain, delayed fur development and increased anxiety-like behavior on PND 25. Thus, this experimental study suggests that intrauterine exposure to ST disrupts the fetal environment and can negatively program serotonin-regulated processes. Furthermore, it impacts thyroid weight when associated with stress.


Subject(s)
Prenatal Exposure Delayed Effects , Sertraline , Humans , Rats , Pregnancy , Animals , Female , Sertraline/toxicity , Rats, Wistar , Reproduction , Body Weight
4.
Toxicol Sci ; 190(2): 189-203, 2022 11 23.
Article in English | MEDLINE | ID: mdl-36161332

ABSTRACT

Despite increased prescription of sertraline during pregnancy, little is known about its action on reproductive development. Therefore, this study aimed to investigate the impact that stress, associated or not with sertraline, causes on the reproductive development of male rats. Pregnant Wistar rats were divided into 4 groups (n = 16/group): CO-received filtered water; SE-received 20 mg/kg sertraline; ST-submitted to restraint stress and received filtered water; SS-submitted to restraint stress and received sertraline. The treatment was carried out from gestational days (GDs) 13-20. The animals were euthanized on GD 20 (n = 8/group), postnatal day (PND) 45 (n = 8/group), and PND 110 (n = 8/group). The testes and epididymis were analyzed histologically, and immunohistochemistry was performed on the testes by proliferating cell nuclear antigen (PCNA) and the Wilms tumor protein (Wt1). Sperm quality was also analyzed on PND 110. The evolution of body weight, anogenital distance (AGD), and puberty installation day were also verified. Statistical analysis: 2-way ANOVA or Kruskal-Wallis test (p ≤ .05). Fetal testes presented a large number of acidophilic cells in the sertraline-exposed groups. The SS group also showed a decrease in the nuclear volume of Leydig cells. This same group showed low expression of PCNA and Wt1, decreased weight of the testes and epididymis, lower AGD, and delayed puberty installation. The adulthood groups exposed to sertraline presented alterations in sperm morphology and motility. The results demonstrated that prenatal exposure to sertraline compromises the development of the rat reproductive system.


Subject(s)
Maternal Exposure , Prenatal Exposure Delayed Effects , Sertraline , Sexual Maturation , Animals , Female , Male , Pregnancy , Rats , Maternal Exposure/adverse effects , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/pathology , Proliferating Cell Nuclear Antigen , Rats, Wistar , Semen , Sertraline/toxicity , Sexual Maturation/drug effects , Testis/pathology
5.
J Neuroendocrinol ; 30(10): e12632, 2018 10.
Article in English | MEDLINE | ID: mdl-29968423

ABSTRACT

Developmental programming refers to processes that occur during early life that may have long-term consequences, modulating adult health and disease. Complex diseases, such as diabetes, cancer and cardiovascular disease, have a high prevalence in different populations, are multifactorial, and may have a strong environmental component. The environment interacts with organisms, affecting their behaviour, morphology and physiology. This interaction may induce permanent or long-term changes, and organisms may be more susceptible to environmental factors during certain developmental stages, such as the prenatal and early postnatal periods. Several factors have been identified as responsible for inducing the reprogramming of various reproductive and nonreproductive tissues. Among them, both natural and synthetic steroids, such as endocrine disruptors, are known to have either detrimental or positive effects on organisms depending on the dose of exposure, stage of development and biological sexual background. The present review focuses on the action of steroids and endocrine disruptors as agents involved in developmental programming and on their modulation and effects on female neuroendocrine functions.


Subject(s)
Endocrine Disruptors/toxicity , Gonadal Steroid Hormones/physiology , Neurosecretory Systems/growth & development , Animals , Female , Humans , Neurosecretory Systems/drug effects , Neurosecretory Systems/physiopathology , Polycystic Ovary Syndrome/physiopathology , Pregnancy , Prenatal Exposure Delayed Effects/physiopathology
6.
Chem Biol Interact ; 291: 202-211, 2018 Aug 01.
Article in English | MEDLINE | ID: mdl-29953847

ABSTRACT

Therapy with betamethasone, a synthetic glucocorticoid, is used in cases of preterm birth risk, in order to promote fetal lung maturation, and decrease neonatal mortality and morbidity. However, late reproductive disorders related to the prenatal exposure to this compound have been reported by our Laboratory, in both male and female rats. Thus, the present study aimed to evaluate the impact of betamethasone on postnatal reproductive development, during pre-puberty, of male offspring exposed in utero to this synthetic glucocorticoid. For this purpose, pregnant Wistar rats were allocated into two groups: Control, treated with saline, and the group treated with betamethasone at 0.1 mg/kg/day. Control and betamethasone groups were treated with intramuscular injection on gestational days 12, 13, 18 and 19, critical days of prenatal reproductive development. The treatment is associated with reduced body and organ weights, disorders in initial reproductive parameters of pre-pubertal male offspring exposed in utero to betamethasone, such as reduction of anogenital distance, alterations in histomorphometric parameters and immunostaining pattern of androgen and estrogen receptors on testicles and epididymides. Our results suggest that prenatal exposure to betamethasone potentially causes reproductive reprogramming and impairs male postnatal reproductive development. This data raise concerns about the use of betamethasone for human antenatal therapy.


Subject(s)
Betamethasone/toxicity , Epididymis/pathology , Prenatal Exposure Delayed Effects/pathology , Sexual Maturation/drug effects , Testis/pathology , Animals , Body Weight/drug effects , Epididymis/drug effects , Female , Male , Organ Size/drug effects , Pregnancy , Rats, Wistar , Receptors, Androgen/metabolism , Receptors, Estrogen/metabolism , Testis/drug effects
7.
J Toxicol Environ Health A ; 80(19-21): 1166-1179, 2017.
Article in English | MEDLINE | ID: mdl-28956719

ABSTRACT

The acute promyelocytic leukemia (APL) is a rare disease, affecting 0.1/100,000 individuals globally. Despite significant advances in APL therapy, some patients still experience relapsed disease. Currently, arsenic trioxide (As2O3) was found to be effective in relapsed APL treatment and considered as standard treatment for these cases. However, it has been shown that exposure to As2O3 may exert adverse effects on the male reproductive system since this substance might also induce apoptosis of other important cell types including stem cells. Studies demonstrated that treatment with this metallic substance decreased plasma levels of testosterone and interfered with sperm parameters such as concentration, motility, and viability. In addition, As2O3 was found to produce significant damage to spermatocytes, which may be associated with testicular toxicity and consequent inhibition of spermatogenesis. The aim of this study was to determine sub-chronic treatment effects of As2O3 on sperm and testicular morphology, androgen receptor (AR) immunoreactivity in testes and epididymis, in addition to evaluation of fertility parameters in adult male mice. Thirty adult Swiss mice were divided into three experimental groups: control; received distilled water (vehicle) while treated received 0.3 or 3 mg/kg/day As2O3 subcutaneously, for 5 days per week, followed by 2 days of interruption, for 5 weeks. Results showed that As2O3 (1) decreased spermatozoa number, (2) produced seminiferous epithelium degeneration and exfoliation of germ cells tubule lumen (3) altered nucleus/cytoplasm proportion of Leydig cells and (4) reduced AR immunoreactivity in both Leydig and epithelial epididymal cells. Further, fetal viability tests demonstrated an increase in post-implantation loss in females that were mated with As2O3-treated males. Data indicate that As2O3 exposure altered the spermatogenic process and subsequently fetal viability.


Subject(s)
Fetal Viability/drug effects , Oxides/toxicity , Testis/drug effects , Animals , Arsenic Trioxide , Arsenicals/administration & dosage , Disease Models, Animal , Epididymis/drug effects , Epididymis/metabolism , Fertility/drug effects , Leukemia, Promyelocytic, Acute/drug therapy , Leydig Cells/drug effects , Leydig Cells/metabolism , Male , Mice , Oxides/administration & dosage , Receptors, Androgen/metabolism , Reproduction/drug effects , Seminiferous Epithelium/drug effects , Seminiferous Epithelium/metabolism , Spermatogenesis/drug effects , Spermatozoa/drug effects , Spermatozoa/metabolism , Testis/metabolism , Toxicity Tests, Subchronic , Weight Gain/drug effects
8.
Oxid Med Cell Longev ; 2017: 2172981, 2017.
Article in English | MEDLINE | ID: mdl-29410731

ABSTRACT

Oxidative stress is known as the leading factor responsible for varicocele-related infertility and for that reason, many antioxidant therapies have been proposed. Considering that, we evaluated the reproductive outcomes and fertility of varicocelized rats and the impact of chrysin within these parameters. The animals were allocated into three groups: sham (control), varicocele treated via gavage with 50 mg/kg/day of chrysin (V1), or vehicle (V2) for 56 days. Chrysin treatment prevented oxidative damage resulting from varicocele by decreasing testicular concentrations of malondialdehyde and sperm DNA fragmentation. It also improved histological aspect of the testis and maintained morphometric parameters similar to the sham group. Furthermore, there were no differences in body and reproductive organ weights, histopathological analysis of epididymis, sperm counts and morphology, testosterone levels, sexual behavior, and fertility parameters among experimental groups. Our results reinforce the idea that injuries provoked by experimental varicocele are related, at least in part, to oxidative stress. Moreover, varicocele showed bilateral deleterious effects without interfering with fertility. Chrysin administration significantly ameliorated sperm parameters, protecting the reproductive system against varicocele damages. For that reason, chrysin might be an alternative adjuvant therapy to improve sperm quality in men presenting this condition.


Subject(s)
Flavonoids/pharmacology , Infertility, Male/drug therapy , Oxidative Stress/drug effects , Sperm Motility/drug effects , Varicocele/drug therapy , Animals , Female , Humans , Infertility, Male/metabolism , Infertility, Male/pathology , Male , Rats , Rats, Wistar , Testis/drug effects , Testis/metabolism , Testis/pathology , Varicocele/metabolism , Varicocele/pathology
9.
Environ Toxicol ; 32(3): 776-788, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27120489

ABSTRACT

Parabens are used as preservatives in cosmetic, pharmaceutical, and food industries, and are frequently detected as contaminants in human fluids and tissues. The endocrine disrupting effects of parabens in female rodents include uterotrophic response, steroidogenesis impairment, and ovarian disturbances. The objective of this study was to determine the effects of maternal butyl paraben (BP) exposure on female sexual development. Pregnant Wistar rats were treated subcutaneously with either corn oil or BP at doses of 10, 100, or 200 mg/kg, from gestational day (GD) 12 until GD 20 for female foetal gonad evaluation, and from GD 12 until the end of lactation to evaluate sexual parameters on the female offspring. Immature female rats were also used in the uterotrophic assay to evaluate the possible estrogenic action of parabens. Our results revealed that, in this experimental protocol, BP did not show estrogenic activity at the doses used and did not impair sexual development and fertility capacity in the female rats, but impaired sexual behavior. We conclude that brain sexual development may be more sensitive to BP effects and we speculate that doses higher than 100 mg/kg (the male lowest observed adverse effect level (LOAEL) for rodent reproductive parameters) would be necessary to promote damages in the female reproduction, regarding the same protocol of exposure. © 2016 Wiley Periodicals, Inc. Environ Toxicol 32: 776-788, 2017.


Subject(s)
Endocrine Disruptors/toxicity , Fertility/drug effects , Parabens/toxicity , Reproduction/drug effects , Animals , Estrus/drug effects , Female , Hormones/blood , Humans , Lactation , Male , Maternal Exposure/adverse effects , Organ Size/drug effects , Ovary/drug effects , Ovary/pathology , Pregnancy , Rats , Rats, Wistar , Sexual Behavior, Animal/drug effects
10.
Reprod Toxicol ; 65: 29-38, 2016 10.
Article in English | MEDLINE | ID: mdl-27352640

ABSTRACT

Exposure to Tetrachlorodibenzo-p-dioxin (TCDD) in male rats promotes, decreased sperm concentration, alterations in motility and in sperm transit time. We evaluated the effect transgenerational of in utero exposure to low doses TCDD in the sperm quality. Pregnant rats (F0) were exposed to 0.1; 0.5 and 1.0µg of TCDD, on gestational day 15, coincides with the end of most organogenesis in the fetus. Adult male offspring (F1, F2 and F3 generation) were investigated for fertility after artificial insemination in utero. After collection of the uterus and ovaries, the numbers of corpora lutea and implants were determined. TCDD provoked alterations in sperm morphology and diminution in serum testosterone levels and sperm transit time in the cauda epididymis. The fertility significantly decreased in all the generations, at least at one dose. In conclusion, TCDD exposure decreases rat sperm quality and fertility in adult male offspring and this effects persist into the next generation.


Subject(s)
Environmental Pollutants/toxicity , Fertility/drug effects , Polychlorinated Dibenzodioxins/toxicity , Prenatal Exposure Delayed Effects , Spermatozoa/drug effects , Animals , Female , Male , Pregnancy , Rats, Wistar , Sperm Count , Sperm Motility/drug effects , Spermatozoa/physiology , Testosterone/blood
11.
Reprod Toxicol ; 60: 112-22, 2016 04.
Article in English | MEDLINE | ID: mdl-26867865

ABSTRACT

Cisplatin (CP) is used to treat a number of cancers, including testicular cancer. Studies indicate that CP-treatment can impair spermatogenesis in humans and rodents by germ cell DNA binding, through different modes of action. CP-paternal exposure resulted in adverse effects in F1 male offspring. In this study, F1 female offspring was assessed for reproductive development after CP-paternal exposure. Peri-pubertal male rats, treated with 1mg/Kg/day of CP or vehicle for 3 weeks, were mated with unexposed females. F1 female offspring of CP-treated fathers showed a decrease in fetal ovary germ cells, in estrous cycle length and FSH levels, and an increase in the percentage of antral follicles in adults. Based on our previous results and the findings of the present work we concluded that CP-paternal exposure leads to adverse effects on rat male and female reproductive development, raising concern, in humans, for children born to men exposed to CP.


Subject(s)
Antineoplastic Agents/toxicity , Cisplatin/toxicity , Paternal Exposure , Prenatal Exposure Delayed Effects , Sex Differentiation/drug effects , Animals , Estrous Cycle/drug effects , Female , Fertility/drug effects , Follicle Stimulating Hormone/blood , Germ Cells/drug effects , Male , Ovary/drug effects , Pregnancy , Rats, Wistar , Sexual Behavior, Animal/drug effects
12.
Environ Toxicol ; 31(11): 1460-1468, 2016 Nov.
Article in English | MEDLINE | ID: mdl-26031391

ABSTRACT

Androgen exposure during sexual development induces alterations in steroidal target tissues. The objective of this study was to evaluate the uterine responsiveness to estradiol after perinatal androgenization. Pregnant Wistar rats were exposed to corn oil or testosterone propionate at 0.05, 0.1, or 0.2 mg/kg from gestational day 12 until postnatal day 21. Female offspring was challenged with estradiol (E2 ) after weaning (0.4 mg/kg) and at adulthood (10 or 100 µg/day), when the pituitary response was also evaluated. At adulthood, control and 0.05 mg/kg groups presented a uterine weight increment when exposed to 100 µg/day of E2 , 0.1 mg/kg group only responded to 10 µg/day of E2 , and the 0.2 mg/kg group showed increased uterine weight at both doses. The pituitary weight was similarly increased after estradiol stimulation in all experimental groups. In conclusion, testosterone propionate exposure induced an abnormal stimulation of uterine tissue growth by estrogen stimulus without affecting pituitary response. More studies are needed to clarify whether these alterations are capable of impairing the reproductive capacity of the female tract. © 2015 Wiley Periodicals, Inc. Environ Toxicol 31: 1460-1468, 2016.


Subject(s)
Estradiol/pharmacology , Prenatal Exposure Delayed Effects/metabolism , Testosterone Propionate/toxicity , Uterus/drug effects , Uterus/pathology , Androgens/toxicity , Animals , Animals, Newborn , Female , Male , Organ Size/drug effects , Pregnancy , Prenatal Exposure Delayed Effects/pathology , Rats , Rats, Wistar , Reproduction/drug effects , Time Factors , Uterus/metabolism
13.
J Appl Toxicol ; 35(9): 1007-16, 2015 Sep.
Article in English | MEDLINE | ID: mdl-25645087

ABSTRACT

Bupropion is a dopamine (DA) and norepinephrine (NE) reuptake inhibitor used as smoking cessation and antidepressant drug with a lower incidence of male sexual dysfunction. We showed previously that sibutramine, a norepinephrine/serotonine reuptake inhibitor, reduced male rat fertility. As there are no studies evaluating the impact of bupropion treatment on spermatic parameters and male fertility, we evaluated the effects of bupropion treatment (15 and 30 mg kg(-1), 30 days) on sexual behavior, spermatic parameters and fertility of male Wistar rats and on the epididymal duct in vitro contractility. Bupropion 15 mg kg(-1) increased the serum luteinizing hormone level and the epididymal duct contractility, but the sperm quality was not affected. At 30 mg kg(-1) bupropion impaired sperm quality increasing the incidence of non-progressive sperm. The male sexual behavior and fertility were not modified at both bupropion doses. These results, in rats, suggest the importance of studies evaluating the effects of bupropion on the human male sperm quality.


Subject(s)
Bupropion/toxicity , Dopamine Uptake Inhibitors/toxicity , Epididymis/drug effects , Muscle Contraction/drug effects , Sperm Transport/drug effects , Spermatozoa/drug effects , Animals , Epididymis/physiopathology , Female , Fertility/drug effects , Luteinizing Hormone/blood , Male , Organ Size/drug effects , Rats, Wistar , Sexual Behavior, Animal/drug effects , Sperm Count , Sperm Motility/drug effects , Spermatozoa/pathology
14.
Biomed Res Int ; 2014: 309631, 2014.
Article in English | MEDLINE | ID: mdl-24772420

ABSTRACT

Methylmercury, organic form of mercury, can increase the number of abnormal sperm and decrease sperm concentration and testosterone levels possibly due to the damage caused by reactive species to germ and Leydig cells. Maná-cubiu (Solanum sessiliflorum Dunal) is a native fruit from Amazon rich in iron, zinc, niacin, pectin, and citric acid, used in foods, beverages, and medicinal purposes, since it has been useful for treatment of various diseases caused by oxidative stress or nutritional deficiency. Therefore, this study evaluated the phytoremediation potential of this fruit on damages caused by exposure to MeHg on sperm quantity and quality and the histological aspect of the testis and epididymis. Wistar male rats (n = 20) were randomly allocated into four groups: Control group (received distilled water), MeHg group (140 µg/Kg), Solanum group (1% of fruit Maná-cubiu on chow), and Solanum plus MeHg group (same treatment as MeHg and Solanum group). The organs were weighted, histopathology; sperm morphology and counts were obtained. The results showed reduction in body weight gain, testis weights, reduced sperm production, and increased histopathological abnormalities in the MeHg-treated group. However, treatment with Solanum plus MeHg revealed a protective effect of this fruit on damages caused by MeHg.


Subject(s)
Biodegradation, Environmental , Methylmercury Compounds/toxicity , Reproduction/drug effects , Spermatozoa/drug effects , Animals , Humans , Male , Oxidative Stress/drug effects , Plant Extracts/administration & dosage , Plant Extracts/chemistry , Rats , Rats, Wistar , Solanum/chemistry
15.
Spermatogenesis ; 4(2): e979114, 2014.
Article in English | MEDLINE | ID: mdl-26413396

ABSTRACT

While most of this Special Issue is devoted to the testis (which is where most drug and chemically induced toxicity of the male reproductive tract is identified), being able to recognize and understand the potential effects of toxicants on the epididymis is immensely important and an area that is often overlooked. The epididymis is the organ where the post-testicular sperm differentiation occurs, through a complex and still not completely understood sperm maturation process, allowing them to fertilize the oocyte. Also in the epididymis, sperm are stored until ejaculation, while being protected from immunogenic reaction by a blood-epididymis barrier. From a toxicologic perspective the epididymis is inherently complicated as its structure and function can be altered both indirectly and directly. In this review we will discuss the factors that must be considered when attempting to distinguish between indirect and direct epididymal toxicity and highlight what is currently known about mechanisms of epididymal toxicants, using the rat as a reference model. We identify 2 distinguishable signature lesions - one representing androgen deprivation (secondary to Leydig cell toxicity in the testis) and another representing a direct acting toxicant. Other commonly observed alterations will also be shown and discussed. Finally, we point out that many of the key functions of the epididymis can be altered in the absence of a detectable change in tissue structure. Collectively, we hope this will provide pathologists with increased confidence in identification of epididymal toxicity and enable more informed guidance as mechanism of action is considered.

16.
Diabetol Metab Syndr ; 5(1): 61, 2013 Oct 16.
Article in English | MEDLINE | ID: mdl-24499555

ABSTRACT

BACKGROUND: Neonatal STZ treatment induces a state of mild hyperglycemia in adult rats that disrupts metabolism and maternal/fetal interactions. The aim of this study was investigate the effect of neonatal STZ treatment on the physical development, behavior, and reproductive function of female Wistar rats from infancy to adulthood. METHODS: At birth, litters were assigned either to a Control (subcutaneous (s.c.) citrate buffer, n = 10) or STZ group, (streptozotocin (STZ) - 100 mg/kg-sc, n = 6). Blood glucose levels were measured on postnatal days (PND) 35, 84 and 120. In Experiment 1 body weight, length and the appearance of developmental milestones such as eye and vaginal opening were monitored. To assess the relative contribution of the initial and long term effects of STZ treatment this group was subdivided based on blood glucose levels recorded on PND 120: STZ hyperglycemic (between 120 and 300 mg/dl) and STZ normoglycemic (under 120 mg/dl). Behavioral activity was assessed in an open field on PND 21 and 75. In Experiment 2 estrous cyclicity, sexual behavior and circulating gonadotropin, ovarian steroid, and insulin levels were compared between control and STZ-hyperglycemic rats. In all measures the litter was the experimental unit. Parametric data were analyzed using one-way or, where appropriate, two-way ANOVA and significant effects were investigated using Tukey's post hoc test. Fisher's exact test was employed when data did not satisfy the assumption of normality e.g. presence of urine and fecal boli on the open field between groups. Statistical significance was set at p < 0.05 for all data. RESULTS: As expected neonatal STZ treatment caused hyperglycemia and hypoinsulinemia in adulthood. STZ-treated pups also showed a temporary reduction in growth rate that probably reflected the early loss of circulating insulin. Hyperglycemic rats also exhibited a reduction in locomotor and exploratory behavior in the open field. Mild hyperglycemia did not impair gonadotropin levels or estrous cylicity but ovarian steroid concentrations were altered. CONCLUSIONS: In female Wistar rats, neonatal STZ treatment impairs growth in infancy and results in mild hyperglycemia/hypoinsulinemia in adulthood that is associated with changes in the response to a novel environment and altered ovarian steroid hormone levels.

17.
J Toxicol Environ Health A ; 75(16-17): 1047-58, 2012.
Article in English | MEDLINE | ID: mdl-22852854

ABSTRACT

Recent studies indicate that several anomalies of the male reproductive system may be produced by acute or chronic exposure to chemical substances released into the environment, attributed to increased industrial development. Among these substances are trace metals such as cadmium (Cd). The aim of this study was to assess reproductive parameters in adult male rats whose mothers were exposed to Cd during pregnancy and lactation. For this, pregnant rats were divided into two experimental groups: treated rats, which received ad libitum cadmium acetate (CdAc) solution in distilled water (10 mg Cd/L), and control rats, which received sodium acetate (NaAc) solution in distilled water (equimolar to the CdAc). The results showed that the exposure to Cd in utero and through lactation adversely affected sperm quality of adult rats, as evidenced by compromised sperm morphology and motility and increased rate of cell death in testis.


Subject(s)
Cadmium/toxicity , Lactation , Prenatal Exposure Delayed Effects , Semen Analysis , Spermatozoa/drug effects , Animals , Cadmium/administration & dosage , Female , Male , Pregnancy , Random Allocation , Rats , Rats, Wistar , Testis/drug effects , Testis/pathology
18.
Pharm Biol ; 50(2): 195-200, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22050261

ABSTRACT

CONTEXT: Jacaranda decurrens subsp. symmetrifoliolata Farias & Proença (Bignoniaceae) is a species widely used for their medicinal properties. At least to our known, no study has been conducted concerning its toxicological profile after gestational and lactational exposure. OBJECTIVE: The present study was carried out to evaluate the effects of J. decurrens on development of the reproductive system in male rats. MATERIALS AND METHODS: Pregnant rats were treated daily (gavage) with 250 or 500 mg/kg/day of aqueous extract of J. decurrens or vehicle, from day 12 of pregnancy to day 21 of lactation. RESULTS AND DISCUSSION: Both doses of J. decurrens significantly anticipated (p < 0.05) the age of testicular descent to the scrotum, a parameter indicative of puberty initiation. Furthermore, at puberty, there was a significant reduction (p < 0.05) in testicular and epididymis weights in the offspring exposed to the higher dose of extract, without effect on sperm production and the histology of reproductive organs. On the other hand, at adulthood, the reproductive parameters analyzed did not differ among groups. CONCLUSIONS: J. decurrens, in this experimental model, interfered with the initial development of the reproductive system, but without lasting effects on sperm production in adulthood.


Subject(s)
Bignoniaceae/chemistry , Plant Extracts/toxicity , Prenatal Exposure Delayed Effects , Reproduction/drug effects , Animals , Dose-Response Relationship, Drug , Epididymis/drug effects , Epididymis/metabolism , Female , Lactation , Male , Maternal Exposure , Plant Extracts/administration & dosage , Pregnancy , Rats , Rats, Wistar , Spermatozoa/metabolism , Testis/drug effects , Testis/metabolism
19.
Fertil Steril ; 96(3): 739-44, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21762892

ABSTRACT

OBJECTIVE: To evaluate the changes in the caput epididymis following cryptorchidism and orchidopexy. DESIGN: Experimental study in a research laboratory. SETTING: Reproductive biology research laboratory. ANIMAL(S): Immature male and mature female mice (C57BL/6). INTERVENTION(S): Experimental cryptorchidism and orchidopexy. MAIN OUTCOME MEASURE(S): Morphometric-stereologic analyses, serum testosterone dosage, immunohistochemical staining of the antigen TRA54 (testicular germ cells immunized to a rat monoclonal antibody), smooth muscle α-actin (SM α-actin) and SM myosin heavy chain, sperm transit time, and fertility parameters. RESULT(S): There was a significant reduction in the morphometric-stereologic parameters in the cryptorchidic mice. These parameters demonstrated significant recovery following orchidopexy. Staining for an androgen-dependent antigen, TRA54, was observed in all groups. SM α-actin and SM myosin heavy chain staining was significantly increased in the cryptorchidism group but stable in the orchidopexy group. Despite the recovery of daily sperm production in the testes, the sperm transit time in the epididymis and fertility parameters remained significantly reduced in the orchidopexy group. CONCLUSION(S): In cryptorchidic animals, there was an acceleration of sperm passage through the epididymal duct. Orchidopexy did not restore the normal passage time. Accordingly, there was a significant reduction in the fertility parameters in the cryptorchidic group that were not fully recovered following orchidopexy.


Subject(s)
Cryptorchidism/surgery , Epididymis/physiology , Infertility, Male/surgery , Orchiopexy , Spermatogenesis/physiology , Animals , Cryptorchidism/physiopathology , Disease Models, Animal , Epididymis/cytology , Epididymis/surgery , Female , Infertility, Male/physiopathology , Male , Mice , Mice, Inbred C57BL , Sperm Motility/physiology , Spermatozoa/cytology , Spermatozoa/physiology , Testis/cytology , Testis/physiology , Testis/surgery , Treatment Outcome
20.
Birth Defects Res B Dev Reprod Toxicol ; 92(5): 478-86, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21770027

ABSTRACT

BACKGROUND: Diuron is widely used in agriculture but its deleterious effects on the reproductive system and mammary gland are still poorly understood. This study evaluated whether early-life-stage exposure to Diuron alters puberty onset or susceptibility to mammary carcinogenesis in female Sprague-Dawley rats. METHODS AND RESULTS: Pregnant rats received basal diet or diet containing Diuron at 500, 750, and 1,250 ppm, from gestational day 12 to the end of lactation (postnatal day 21 [PND21]). After weaning, female offspring continued receiving basal diet or diet containing Diuron until PND 51. At PND 51, female Sprague-Dawley offspring received a single dose of 50 mg/kg b.w. of 7,12-dimethylbenz(a)anthracene (DMBA) for initiation of mammary carcinogenesis. The animals were sacrificed on PND 51, 75, and 226 to 233 (week 25) for mammary gland morphology, reproductive organs and tumor analysis, respectively. There were no significant differences among groups on vaginal opening, estrous cycle, mammary morphology, or carcinogenesis. However, reductions in ovary weight and corpora lutea were observed at PND 75 in the group treated with Diuron at 1,250 ppm. CONCLUSIONS: The findings suggesting that Diuron exposure (1,250 ppm) may have been potentially toxic to the ovaries.


Subject(s)
Diuron/toxicity , Ovary/drug effects , Reproduction/drug effects , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Female , Maternal Exposure/adverse effects , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...